Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes

Acta Neuropathologica

Volumn 118, Issue 3, 2009, Pages 349-358

  Josephs, Keith A ^a   Stroh, Alex ^b   Dugger, Brittany ^b   Dickson, Dennis W ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Frontotemporal dementia; Frontotemporal lobar degeneration; Immunohistochemistry; Progressive non fluent aphasia; Semantic dementia; TDP 43

Indexed keywords

TAR DNA BINDING PROTEIN;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN STEM; CELL INCLUSION; DIENCEPHALON; DISEASE CLASSIFICATION; FEMALE; FRONTAL LOBE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA WITH UBIQUITIN IMMUNOREACTIVE INCLUSION; HIPPOCAMPUS; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOGLOSSAL NUCLEUS; INFERIOR OLIVE; MAJOR CLINICAL STUDY; MALE; NEURITE; NEURONAL CYTOPLASMIC INCLUSION; PARIETAL LOBE; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA; SEMANTIC DEMENTIA; SUBSTANTIA NIGRA; TEMPORAL LOBE; THALAMUS;

AGED; AGED, 80 AND OVER; BASAL GANGLIA; BRAIN STEM; CEREBRAL CORTEX; DEMENTIA; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MALE; MIDDLE AGED; NEURONS;

EID: 68349088087     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-009-0547-7     Document Type: Article

References (38)

1. Baker M, Mackenzie IR, Pickering-Brown SM et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442:916-919. doi: 10.1038/nature05016
2. Beach TG, White CL, Hamilton RL et al (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116:277-288. doi: 10.1007/s00401-008-0409-8
3. Cairns NJ, Bigio EH, Mackenzie IR et al (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5-22. doi: 10.1007/s00401-007-0237-2
4. Cairns NJ, Grossman M, Arnold SE et al (2004) Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 63:1376-1384
5. Dachsel JC, Ross OA, Mata IF et al (2007) Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions. Acta Neuropathol 113:601-606. doi: 10.1007/s00401-006-0178-1
6. Davidson Y, Kelley T, Mackenzie IR et al (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113:521-533. doi: 10.1007/s00401-006-0189-y
7. Dickson DW (2005) Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Acta Neuropathol 109:14-24. doi: 10.1007/s00401-004-0950-z
8. Dickson DW, Josephs KA, Amador-Ortiz C (2007) TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol 114:71-79. doi: 10.1007/s00401-007-0234-5
9. Forman MS, Farmer J, Johnson JK et al (2006) Frontotemporal dementia: clinicopathological correlations. Ann Neurol 59:952-962. doi: 10.1002/ ana.20873
10. Grossman M, Wood EM, Moore P et al (2007) TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions. Arch Neurol 64:1449-1454. doi: 10.1001/ archneur.64.10.1449
11. Gwinn-Hardy K, Mehta ND, Farrer M et al (2000) Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol 99:663-672. doi: 10.1007/s004010051177
12. Hatanpaa KJ, Bigio EH, Cairns NJ et al (2008) TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: A midwest-southwest consortium for FTLD study. J Neuropathol Exp Neurol 67:271-279. doi: 10.1097/NEN.0b013e31816a12a6
13. Hodges JR, Davies RR, Xuereb JH et al (2004) Clinicopathological correlates in frontotemporal dementia. Ann Neurol 56:399-406. doi: 10.1002/ana.20203
14. Josephs KA, Ahmed Z, Katsuse O et al (2007) Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 66:142-151. doi: 10.1097/nen.0b013e31803020cf
15. Josephs KA, Dickson DW (2007) Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration. Neurobiol Aging 28:1718-1722. doi: 10.1016/j.neurobiolaging.2006.07.010
16. Josephs KA, Dickson DW (2007) Frontotemporal lobar degeneration with upper motor neuron disease/primary lateral sclerosis. Neurology 69:1800-1801. doi: 10.1212/01.wnl.0000277270.99272.7e
17. Josephs KA, Holton JL, Rossor MN et al (2003) Neurofilament inclusion body disease: A new proteinopathy? Brain 126:2291-2303. doi: 10.1093/ brain/awg231
18. Josephs KA, Holton JL, Rossor MN et al (2004) Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 30:369-373. doi: 10.1111/j.1365-2990.2003.00545.x
19. Josephs KA, Knopman DS, Whitwell JL et al (2005) Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology 65:645-647. doi: 10.1212/01.wnl.0000173178.67986.7f
20. Josephs KA, Lin WL, Ahmed Z, Stroh DA, Graff-Radford NR, Dickson DW (2008) Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions. Acta Neuropathol 116:159-167. doi: 10.1007/ s00401-008-0397-8
21. Josephs KA, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW (2006) Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. Arch Neurol 63:506-512. doi: 10.1001/archneur.63.4.506
22. Josephs KA, Petersen RC, Knopman DS et al (2006) Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66:41-48. doi: 10.1212/01.wnl.0000191307.69661.c3
23. Josephs KA, Uchikado H, McComb RD et al (2005) Extending the clinicopathological spectrum of neurofilament inclusion disease. Acta Neuropathol 109:427-432. doi: 10.1007/s00401-004-0974-4
24. Katsuse O, Dickson DW (2005) Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease. Alzheimer Dis Assoc Disord 19(Suppl 1):S37-S43. doi: 10.1097/01.wad.0000183889.61421.a8
25. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG (2005) The evolution and pathology of frontotemporal dementia. Brain 128:1996-2005. doi: 10.1093/brain/awh598
26. Mackenzie IR (2007) The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathol 114:49-54. doi: 10.1007/ s00401-007-0223-8
27. Mackenzie IR, Baborie A, Pickering-Brown S et al (2006) Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: Classification and relation to clinical phenotype. Acta Neuropathol 112:539-549. doi: 10.1007/s00401-006-0138-9
28. Mackenzie IR, Neumann M, Bigio EH et al (2009) Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: Consensus recommendations. Acta Neuropathol 117:15-18. doi: 10.1007/ s00401-008-0460-5
29. McCluskey LF, Elman LB, Martinez-Lage M et al (2009) Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology. Arch Neurol 66:121-124. doi: 10.1001/archneur.66.1.121
30. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58:1803-1809. doi: 10.1001/archneur.58.11.1803
31. Neary D, Snowden JS, Gustafson L et al (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51:1546-1554
32. Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130-133. doi: 10.1126/science.1134108
33. Pikkarainen M, Hartikainen P, Alafuzoff I (2008) Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry. J Neuropathol Exp Neurol 67:280-298. doi: 10.1097/ NEN.0b013e31816a1da2
34. Sampathu DM, Neumann M, Kwong LK et al (2006) Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 169:1343-1352. doi: 10.2353/ajpath.2006.060438
35. Snowden J, Neary D, Mann D (2007) Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol 114:31-38. doi: 10.1007/s00401-007-0236-3
36. Thompson SA, Patterson K, Hodges JR (2003) Left/right asymmetry of atrophy in semantic dementia: Behavioral-cognitive implications. Neurology 61:1196-1203
37. Togo T, Cookson N, Dickson DW (2002) Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 12:45-52
38. Uchikado H, Li A, Lin WL, Dickson DW (2006) Heterogeneous inclusions in neurofilament inclusion disease. Neuropathology 26:417-421. doi: 10.1111/ j.1440-1789.2006.00709.x